Neo Ivy Capital Management’s Boston Scientific BSX Stock Holding History

Neo Ivy Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$893K	Buy	+14,236	New	+$1.14M	0.24%	150
2025 Q3	–	Sell	-7,392	Closed	-$794K	–	399
2025 Q2	$794K	Buy	+7,392	New	+$748K	0.25%	139
2022 Q2	–	Sell	-2,498	Closed	-$110K	–	416
2022 Q1	$110K	Buy	2,498 +531	+27%	+$23K	0.1%	293
2021 Q4	$84K	Sell	1,967 -11,574	-85%	-$486K	0.12%	235
2021 Q3	$475K	Buy	13,541 +486	+4%	+$21.5K	0.54%	57
2021 Q2	$558K	Buy	13,055 +8,321	+176%	+$350K	0.56%	48
2021 Q1	$183K	Buy	+4,734	New	+$179K	0.2%	169
2020 Q4	–	Sell	-17,085	Closed	-$652K	–	427
2020 Q3	$652K	Buy	17,085 +3,544	+26%	+$137K	0.66%	27
2020 Q2	$475K	Buy	13,541 +8,081	+148%	+$291K	0.54%	57
2020 Q1	$178K	Buy	+5,460	New	+$213K	0.29%	134
2019 Q4	–	Sell	-525	Closed	-$22K	–	273
2019 Q3	$22K	Buy	+525	New	+$22.2K	0.01%	255

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Neo Ivy Capital Management's BSX Position: Q1 2026 in Review

Neo Ivy Capital Management opened a new position in Boston Scientific (BSX) in Q1 2026: 14,236 shares worth $893K. The stake represents 0.24% of the portfolio and ranks #150 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in BSX as recently as Q2 2025.

Neo Ivy Capital Management first reported a position in BSX in Q3 2019 and has held it in 11 quarters since. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Neo Ivy Capital Management held 14,236 shares of Boston Scientific worth $893K as of Q1 2026.
Boston Scientific was a new Neo Ivy Capital Management position in Q1 2026.
Boston Scientific made up 0.24% of Neo Ivy Capital Management's portfolio in Q1 2026, its #150 holding.
Neo Ivy Capital Management first reported a position in Boston Scientific in Q3 2019 and has held it in 11 quarters since.
1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.